BrightSpring (BTSG) Q2 Revenue Jumps 29%
BrightSpring Health Services (NASDAQ:BTSG), a leading provider of integrated pharmacy and home-based healthcare services, released its second quarter 2025 results on August 1, 2025. The report showed GAAP revenue of $3,148 million, exceeding analyst estimates of $2,989.69 million. Adjusted earnings per share (EPS) came in at $0.22, surpassing the estimate of $0.19 and marking a significant increase compared to $0.06 in Q2 2024. Adjusted EBITDA (non-GAAP) reached $143 million, up sharply from $111 million in Q2 2024. Net income from continuing operations (GAAP) was $8.5 million, unchanged from Q2 2024. The quarter demonstrated solid top-line expansion, improved earnings metrics, and a raise in full-year guidance, even as profitability at the bottom line remained flat.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
BrightSpring Health Services focuses on delivering both pharmacy and home-based clinical care to patients with complex medical needs. The company combines large-scale medication dispensing with primary care, rehab, personal care, and other medical services in home and community settings. Its integrated approach allows it to serve over 450,000 patients at any one time, fill more than 41 million prescriptions in 2024, and provide approximately 19 million hours of care in 2024.
Source Fool.com
